共 40 条
- [22] Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial (vol 4, pg e165, 2017) LANCET HAEMATOLOGY, 2017, 4 (06): : E257 - E257
- [24] Allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis or acute myeloid leukaemia secondary to a previous polycythaemia vera or essential thrombocythaemia: report from the MDS subcommittee of the Chronic Leukaemia Working Party BONE MARROW TRANSPLANTATION, 2011, 46 : S361 - S361
- [27] Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial LANCET HAEMATOLOGY, 2017, 4 (04): : E165 - E175